Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials-V45I11 Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials-V45I11 Download Melatonin suppression does not automatically alter sleepiness, vigilance, sensory processing, or sleep-V45I11 Association of sleep abnormalities in older adults with risk of developing Parkinson’s disease-V45I11
